David Bunka
University of Leeds
Tell me more about David Bunka?
David Bunka is a Co-founder and CTO of Aptamer Group, a biotechnology company specializing in custom synthesis of high-affinity nucleic acid aptamers. He is also the Co-founder and CTO of Aptamer Diagnostics, AptaDx, AptaRx, and AptaSort. Aptamer Therapeutics is a CRO developing lead molecules for the development of aptamer based therapeutics and the development of a ground-breaking biomarker discovery platform. With over 17 years of experience in molecular biology, David specializes in selection and characterization of DNA and RNA aptamers. He has worked at Apt
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Co-founder and CTO of the Aptamer Group which consists of: Aptamer Solutions (Aptasol), Aptamer Diagnostics (AptaDx), Aptamer Therapeutics (AptaRx) and AptaSort . Aptamer Solutions a biotechnology company specialising in the custom synthesis of high-affinity and highly specific nucleic acid aptamers. Aptamer Diagnostics specialises in the development of aptamer based diagnostic devices and the integration of aptamers into common diagnostic formats such as LFDs and ELISA. Aptamer Therapeutics is a CRO developing lead molecules for the development of aptamer based therapeutics. We also in the process of developing a ground-breaking biomarker discovery platform (AptaSort) which is set to revolutionise aptamer based biomarker discovery. I am a Research Scientist, with over 17 years experience in the field of Molecular Biology, specialising in the isolation and characterisation of nucleic acid aptamers. Before establishing Aptamer Solutions Ltd, with my business partner (Dr Arron Tolley) I spent 12 years at the University of Leeds developing processes for automated selection of nucleic acid aptamers against a variety of targets.Specialties: Selection and characterisation of DNA & RNA aptamers against a wide variety of targets ranging from small molecules and proteins to complexes, viruses and whole cells. Protein expression and purification, DNA and RNA production and purification, fluorescence spectroscopy, UV absorbance spectroscopy, SELEX, in vitro selection, nucleic acid aptamers, aptamers, immunoprecipitation, high throughput screening platforms.
...See MoreWork Experience
Chief Strategy Officer
Director | Chief Technology Officer
Chief Technology Officer
Biotechnology Research
David Bunka's Professional Milestones
- Director | Chief Technology Officer (2014-05-01~): Maximizing performance and efficiency across the organization through strategic analytics and business development initiatives.
- Chief Technology Officer: Driving technological advancements and transforming the company's technological infrastructure to drive business growth and customer satisfaction.
Education
Molecular Biology
Skill
Molecular Biology
Aptamers
Assay Development
Flow Cytometry
Confocal Microscopy
Tissue Culture
Selex
Biomarker Discovery
Facs Analysis
Certification
Colleagues
John Richards
Non-Executive Director
Subir Singh
team manager team leader project manager biobank manager personalised cancer treatment drug screening cell biobiologist drug development onclology ngs team lead
Alastair Fleming
Chief Operating Officer Operations Consultant
Angela Hildreth
finance director chief operating officer at futura medical plc
ILKNUR DERELI
Business Development Associate Director
Other Named David Bunka
Frequently asked questions
We found 2 David Bunka's email addresses
We found 1 David Bunka's phone numbers
David Bunka's social media include: Linkedin,
David Bunka works for Aptamer Group
David Bunka's role in Aptamer Group is Chief Strategy Officer
David Bunka works in the industry of Biotechnology Research
David Bunka's colleagues are John Richards,Subir Singh,Alastair Fleming
David Bunka's latest job experience is Chief Strategy Officer at Aptamer Group
David Bunka's latest education in University of Leeds